Lymphoplasmacytic lymphoma: Difference between revisions
From IDWiki
(Imported from text file) |
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
||
| Line 7: | Line 7: | ||
* SPEP and immunofixation showing IgM-kappa M-protein |
* SPEP and immunofixation showing IgM-kappa M-protein |
||
== Clinical |
== Clinical Manifestations == |
||
* Hyperviscosity, including neurological symptoms |
* Hyperviscosity, including neurological symptoms |
||
Revision as of 12:35, 19 July 2020
Definition
- Low-grade B-cell neoplasm frequently causing an IgM gammopathy (at which point it is called Waldenstrom's macroglobulinemia)
Investigations
- SPEP and immunofixation showing IgM-kappa M-protein
Clinical Manifestations
- Hyperviscosity, including neurological symptoms
- Peripheral neuropathy
- Lymphadenopathy, organomegaly, cytopenia
- Constitutional symptoms
Management
- Depends on underlying health and age
- Treatment only indicated if symptoms progressing
- From most to least effective (and most to least side effects):
- RCP: rituximab, cyclophosphamide, prednisone (or dexamethasone for DRC)
- BR: bendamustine/rituximab
- Chlorambucil/Obinutuzumab
- Ibrutinib
- Before chemotherapy, screen for hepatitis B +/- TB/Strongy
